Actively Recruiting

Phase Not Applicable
Age: 4Years - 11Years
All Genders
NCT07004803

Virtual Reality on Pain and Fear Levels of Children With Primary Immunodeficiency

Led by Dr. Hatice Dönmez · Updated on 2025-06-04

32

Participants Needed

1

Research Sites

56 weeks

Total Duration

On this page

Sponsors

D

Dr. Hatice Dönmez

Lead Sponsor

K

Karamanoğlu Mehmetbey University

Collaborating Sponsor

AI-Summary

What this Trial Is About

In this study, it is aimed to investigate the effect of virtual reality and tablet video viewing intervention on pain and fear levels and vital signs of children during peripheral venous catheter placement for intravenous immunoglobulin (IVIG) administration.

CONDITIONS

Official Title

Virtual Reality on Pain and Fear Levels of Children With Primary Immunodeficiency

Who Can Participate

Age: 4Years - 11Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Be between the ages of 4 and 11 years
  • Have been diagnosed and followed up for Primary Immunodeficiency for at least 6 months
  • Agree to participate in the study voluntarily
  • Have no other chronic diseases besides primary immunodeficiency
Not Eligible

You will not qualify if you...

  • Have organ failure
  • Have a mental deficiency
  • Be unable to use virtual reality glasses
  • Have a fever higher than 37.5 degrees Celsius
  • Have severe dehydration

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Karamanoglu Mehmetbey University

Karaman, Turkey (Türkiye)

Actively Recruiting

Loading map...

Research Team

H

Hatice Dönmez, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

CROSSOVER

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here